E. Negretti

Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.

A. Santoro, G. Bonadonna, P. Valagussa, 1990, Annals of oncology : official journal of the European Society for Medical Oncology.

Timing of Surgery and the Role of Cytoreductive Chemotherapy in Patients with Advanced Ovarian Carcinoma

L. Gianni, M. Zambetti, L. Luciani, 1988, Tumori.

Preliminary Studies on Melatonin in the Treatment of Myelodysplastic Syndromes Following Cancer Chemotherapy

A. Santoro, G. Sozzi, F. Fraschini, 1990, Journal of pineal research.

Testicular dysfunction in Hodgkin's disease before and after treatment.

A. Santoro, G. Bonadonna, P. Valagussa, 1991, European journal of cancer.

Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).

A. Santoro, R. Zucali, S. Viviani, 1994, International journal of radiation oncology, biology, physics.

Morphologic, Immunologic, and Cytogenetic Characteristics of Secondary Acute Unclassifiable Leukemia in Hodgkin's Disease

F. Rilke, G. Cattoretti, G. Sozzi, 1988, Tumori.

Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience.

A. Santoro, G. Bonadonna, R. Zucali, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II Study of Interferon α‐2a and Dacarbazine in Advanced Melanoma

N. Cascinelli, B. Giannotti, G. Zumiani, 1990 .